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ABSTRACT

Evolving out of a need to address growing concerns regarding current methods
of tissue transplantation, the field of tissue engineering seeks to facilitate the
regeneration of viable tissue through the use of cellular scaffolds. The first aim of this
thesis was to provide a summary of the current literature on advances in biomaterial
synthesis and pertaining methods of stem cell delivery in tissue engineering.
Improvements in the processing of decellularized tissue and the expansion of synthetic
hydrogels as platforms for stem cell encapsulation have led to the development of
extracellular matrix (ECM)-based hybrid hydrogels. These stem cell scaffolds are
currently being explored as biomaterials for the purpose of tissue regeneration.
The second aim of this thesis was to fabricate a hybrid synthetic/adipose-derived
ECM hydrogel. Decellularized adipose tissue was incorporated, at varying
concentrations, with a thiol-acrylate fraction that was then polymerized to produce
hydrogels via a Michael addition reaction. Hydrogels were characterized based on their
ability to support the proliferation, maintain the viability and retain the multipotency of
human adipose-derived stem cells (hASCs). Cells encapsulated in hydrogels
containing high concentrations of ECM demonstrated greater expression of human
potency markers compared to cells encapsulated in ECM-free synthetic hydrogels or in
Matrigel®, indicating that adECM hydrogels hold promise as a cost-effective platform for
mesenchymal stem cell multipotency maintenance for tissue engineering applications.
Inspired by the findings that adipose-derived ECM can be converted into a
cytocompatible hydrogel after combination with a synthetic fraction, efforts were
conducted in order to improve the performance of the hybrid synthetic/adipose-derived
ECM hydrogel platform. ECM was thiolated prior to hydrogel synthesis in order to
promote more uniform dispersion. Thiolated adipose-derived ECM hydrogels were
characterized based on their ability to maintain hASC viability. It was found that hASCs
seeded on hydrogels containing higher concentrations of thiolated adECM (tadECM)
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demonstrated decreased viability compared to tadECM-free hydrogels. As these results
may be caused by incomplete thiol-acrylate conversion, increasing the thiol concentration
of the tadECM prior to hydrogel synthesis may lead to improved outcomes.
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1. CURRENT BIOMATERIALS AND PERTAINING STEM CELL DELIVERY
METHODOLGIES IN TISSUE ENGINEERING LITERATURE REVIEW

The field of tissue engineering seeks to regenerate viable tissue through the use of
cell-scaffold systems. When employing stem cells for the generation of functional
tissue, these scaffolds have the potential to promote cellular expansion and to affect
cellular lineage commitment. This brief review aims to provide insight into the various
types of biomaterials used for cell scaffold synthesis. In addition, this work offers a
summary of the considerations for stem cell scaffold design, pertinent methods
employed for stem cell delivery, and examples of current stem cell scaffold systems.

1.1 Tissue Engineering, Mesenchymal Stem Cells, and Cellular Scaffold Design

Every day, thousands of surgical procedures are performed to replace or repair
damaged or injured tissue.1 Evolving out of a need to address concerns pertaining to
tissue transplantation, including the limited availability of healthy tissue, the field of
tissue engineering seeks to facilitate the generation of viable tissue though the
combination of cells and a cellular scaffold.1,2 Mesenchymal stem cells (MSCs) are
multipotent stromal cells most commonly derived from adult bone marrow or adipose.3
Due to their ability to be easily grown and selectively differentiated in vitro, MSCs are
widely used in the field of tissue engineering.4 It has been demonstrated that MSCs
have the ability to differentiate into a variety of cell types, including adipocytes,5
mycoytes,4 osteoblasts,6 and chondrocytes.7 To date, two dimensional (2D) cell
culture has been the most common platform for in vitro culture of MSCs. However,
cellular differentiation and tissue development is a three-dimensional (3D) process—
native cells interact with each other, the ECM, and their surrounding microenvironment
in a 3D fashion.8 The additional dimensionality influences the spatial organization of
cell surface proteins, which ultimately effects gene expression and cellular behavior.9
In addition, 3D conditions modulate the transport of nutrients, gases, and effector
proteins differently than a 2-D environment.10 As a result, cells cultured in a 3D
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environment differ genetically, physiologically,11 and morphologically from cells cultured
in 2D.12 The inability of 2D culture to accurately model the 3D environment of native
tissue has motivated the development of 3D cellular scaffolds for cell-based studies in
the fields stem cell research and tissue regeneration.
Tissue engineering scaffolds can be divided into three distinct groups of
biomaterials—ceramics, synthetic polymers, and natural polymers. The ideal stem cell
scaffold fulfills several design requirements. First, the scaffold is biodegradable,
meaning that it is able to be broken down in vivo, preferably at the same rate as host’s
cells’ colonization of the scaffold.13 Secondly, the biomaterial should be
cytocompatible, meaning cells function normally once they adhere to or are
encapsulated in the scaffold.14 The material should also be broadly biocompatible and
its by-products should also evoke a minimal host response, once implanted, as to not
cause rejection of the implant by the host or inhibit the healing process.15,16
Additionally, the biomaterial’s mechanical properties should closely match that of the
tissue surrounding the defect site.17 Furthermore, the morphology and structure should
incorporate interconnected pores to facilitate cell proliferation, nutrient diffusion, and
waste removal.18 Pores should be small enough to maintain a high specific surface
area, allowing for efficient cellular adhesion, but large enough to facilitate cell migration
through the scaffold.19 Moreover, in order to become commercially and clinically
sustainable, scaffold synthesis methods should have the ability to be translated into
reproducible and robust manufacturing processes.20 Finally, scaffolds designed for
stem cell colonization should be able to effectively direct desired cellular fate. 21 To
date, numerous varieties of scaffolds have been used in combination with MSCs in an
effort to regenerate various tissue types.
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1.2 Naturally-Derived Biomaterials for Tissue Engineering

1.2.1 Commonly Used Naturally-Derived Polymers
The need for biodegradable and biocompatible materials to act as stem cell
scaffolds has led to the widespread use of naturally-derived biomaterials for tissue
regeneration. These biomimetic scaffolds can be categorized as either protein-based or
polysaccharide-based polymers. Due to their capacity to mimic native extracellular
matrix (ECM), protein-derived polymers, such as gelatin,22 collagen,23 fibrin,24,25 and
silk,26 have the potential to support cellular organization, migration, and proliferation
during the process of tissue generation. For example, El-Jawhari et al. demonstrated
that the incorporation of collagen into bone marrow-derived MSC scaffolds significantly
improved cellular attachment and proliferation in vitro.27
Alternatively, polysaccharide-derived polymers can be obtained from microbial,
vegetal, or animal sources.28 It has been demonstrated that these biomaterials, such
as hyaluronan,29 chitosan,30 starch,31 and alginate,32 have the capacity to maintain
cellular viability and support stem cell differentiation. Yoon et. al found that hyaluronic
acid-based scaffolds supported chondrogenic differentiation of adipose-derived MSCs
cultured with bone morphagenic protein-2 (BMP-2).33 In addition, polysaccharidederived polymers have low toxicity and can be produced relatively inexpensively.34,35
However, although naturally-derived biomaterials have been widely used as stem cell
scaffolds, their poor mechanical tunability and sometimes high batch-to-batch variation
has led to further research aimed at addressing these shortfalls.36
1.2.2 Decellularized Tissue Scaffolds
The ECM of the human body is a gel-like, fibrous network that provides mechanical
support and biochemical cues to cells that makeup the body’s tissues.37,38 ECM—
which includes structural proteins, growth factors, proteoglycans, glycosaminoglycans,
and proteolytic enzymes—has been implicated in cellular proliferation, differentiation,
morphogenesis, adhesion, and migration.39 The recognition of ECM as being integral
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to directing stem cell behavior has led to the production and use of scaffolds derived
from decellularized tissue. These protein-based biomaterials offer the capability to
simulate the role that native ECM plays in the process of tissue generation. Once tissue
is harvested from allogeneic or xenogeneic donors,40 it is decellularized, often using
detergents,41 chemical agents,42 enzymes,43 or a combination of these.44 Nucleases
and detergents may also be utilized to remove residual DNA.45,46 Removing the
donor’s cells and cell remnants from the scaffold allows for a drastically lessened host
immune response, post-implantation, compared to current organ transplant
procedures.47 For some applications, such as whole-organ scaffolds, in which
preserving ECM structure and bioactivity are paramount,48 tissue processing ends after
decellularization. However, in instances when ECM derivatives, such as structural
proteins, are required for scaffold synthesis, tissues are further digested, typically by
employing chemical or enzymatic methods.49,50 It has been shown that tissue can be
decellularized and processed in such a way that the risk of an adverse host immune
response is minimized while scaffolds largely maintain their bioactivity profile.51,52
Such scaffolds have been used to facilitate the regeneration of multiple types of
functional tissues.53,54 Table 1.1 demonstrates current clinical products that are
composed of decellularized tissues.55 Although ECM-derived scaffolds offer the
capability to serve as highly bioactive grafts, like many other naturally-derived scaffolds,
their relatively limited mechanical adjustability and batch-to-batch variation hinders their
versatility as platforms for tissue regeneration.56,57
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Table 1.1 - Clinical products composed of decellularized tissue.55
Product
Alloderm®
Strattice™
Zimmer Collagen Repair Patch™
TissueMend®
Oasis®, Surgisis®
Restore™
FortaFlex®
Meso BioMatrix™
MatriStem®
GraftJacket®
OrthAdapt®, Unite®
NeoForm™
AlloPatch HD™, FlexHD®
CopiOs®
Lyoplant®
CorMatrix ECM™
Perimount®
Hancock® II, Mosaic®,
Freestyle®
Prima™ Plus
Epic™, SJM Biocor®

Tissue Source
Human dermis
Porcine dermis
Porcine dermis
Bovine dermis
Porcine small intestine
Porcine small intestine
Porcine small intestine
Porcine mesothelium
Porcine urinary
bladder
Human dermis

Application Focus
Soft tissue
Soft tissue
Soft tissue
Soft tissue
Soft tissue
Soft tissue
Soft tissue
Soft tissue

Porcine heart valve

Valve replacement

Porcine heart valve
Porcine heart valve

Valve replacement
Valve replacement

Soft tissue
Soft tissue, chronic
wounds
Soft tissue, chronic
Equine pericardium
wounds
Human dermis
Breast
Human dermis
Tendon, breast
Bovine pericardium
Dentistry
Bovine pericardium
Dura mater
cardiac
Porcine small intestine Pericardium,
tissue
Bovine pericardium
Valve replacement

1.3 Synthetic Hydrogels and Stem Cell Encapsulation in Tissue Engineering

1.3.1 Synthetic Hydrogels
Hydrogels are hydrophilic materials, composed of one or more monomers, that
have the ability to retain relatively large amounts of water without dissolving.58 Their
largely aqueous makeup is considered to be integral to their capacity to be
biocompatible.59 Hydrogels can be constructed using either synthetic or naturallyderived materials and can be polymerized via chemical or physical crosslinking.60-63
Commonly used synthetic monomers for hydrogel synthesis include polyethylene glycol
(PEG),64 polyvinyl alcohol (PVA),65 and polyacrylamide (PAM).66 These hydrogels
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can be engineered to be permeable to small molecules, such as gases, low molecular
weight metabolites, and ions.67 This allows cells encapsulated in the material to
receive nutrients and oxygen, and for removal of waste to take place.68 In addition,
due to their large number of polar reactive sites, synthetic hydrogels have the ability to
anchor biologically active molecules.69 This versatility has allowed researchers to
modulate the adhesion, migration, and proliferation of mesenchymal stem cells cultured
on or within synthetic hydrogels for the purpose of tissue regeneration.70,71 Hydrogels
created using synthetic polymers also have largely-tunable mechanical
characteristics.72,73 This makes them an attractive tool for stem cell culture in that
substrate-level elasticity plays a significant role in stem cell fate.74 Therefore, as
Engler et. al demonstrated, by modifying substrate stiffness, it is possible to control
mesenchymal stem cell lineage and commitment.74 As such, there has been an
increase in research dedicated to the development of synthetic hydrogels as functional
3D stem cell scaffolds due to their ability to be finely adjusted in terms of composition
and mechanical behavior.
1.3.2 Stem Cell Encapsulation in Synthetic Hydrogels
In the utilization of hydrogels as platforms for tissue regeneration, there are two
common methods of stem cell seeding that are generally employed. One strategy is to
seed stem cells on the scaffold surface, allowing them to adhere to the porous
structure.75 In this scenario, hydrogels are prefabricated, allowing researchers to use a
wider range of polymerization methods, as long as the resultant scaffold is
cytocompatible.75 Alternatively, cells may be encapsulated within the hydrogel
precursor solution prior to polymerization.76 This approach necessitates that suitable
materials and bioorthogonal chemical reactions be used in the polymerization process
in order to maintain cellular viability and functionality.77 However, cell encapsulation
has several benefits in in vivo applications. First, hydrogel precursor solutions have the
potential to be injected into a tissue defect site instead of being cast into a desirable
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shape prior to implantation.78 In addition, as opposed to requiring sutures or glue, an
injected solution has the ability to diffuse through nearby tissue for effective adhesion.79
Optimally, scaffold design should allow for in vivo degradation of the hydrogel to
progress at the same rate as tissue regeneration.8
Largely due to its relative stability in vivo,80 PEG has been the most widely used
synthetic monomer for hydrogel encapsulation.75 It also has ability to be easily
functionalized, allowing for polymer crosslinking density, and therefore, its mechanical
properties, including degradation rate, to finely controlled.81,82 From a bioactivity
perspective, however, PEG hydrogels are relatively inert.83 Alone, their inability to
mimic bioactive molecules in the native ECM significantly limits their capacity to
promote tissue regeneration.84
1.4 ECM-based Hybrid Hydrogel Scaffolds

In an effort to construct a 3D scaffold that combines the bioactivity of native tissues
with the mechanical adjustability of synthetic hydrogels, researchers have designed
hybrid hydrogels to promote stem cell proliferation and differentiation.

While some

investigations have been directed towards combining natural polymers, such as alginate
and collagen,85,86 with synthetic fractions, numerous studies have employed synthetic
oligopeptides to promote cellular attachment and proliferation.87-89 These designer
peptides, which often contain the Arginylglycylaspartic acid (RGD) motif, are commonly
conjugated to synthetic polymers using bioorthogonal chemical reactions, resulting in a
functionalized hydrogel.90,91

Although the incorporation of designer peptides into

hydrogels offers a convenient means of introducing a level of bioactivity into an otherwise
inert scaffold platform, synthetic peptides deliver a relatively limited source of biologic
information to adherent cells.92,93 As a result, they are unable to fully recapitulate
proteins found in the native ECM.94 In addition, designer peptides can be costly to
produce in substantial quantities.95 Therefore, due to its potential to mimic native ECM,
there is an area of research dedicated to the integration of decellularized tissue and its
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derivatives into synthetic hydrogels.

Notably, Grover, et. al demonstrated that

decellularized myocardial matrix could be combined with PEG to promote cellular
migration and adhesion.96 Furthermore, Visser et. al showed that a blend of
decellularized cartilage, meniscus, and tendon tissue could be functionalized and
integrated with a gelatin methacrylamide hydrogel to affect chondrogenic differentiation
in encapsulated MSCs.97 These studies indicate that ECM-based hybrid hydrogels have
the potential to affect stem cell differentiation, and therefore, tissue regeneration, by
means of a biologically complex, mechanically tunable scaffold.
1.5 Future Work and Conclusion

While the field of tissue engineering has seen rapid progression in the evolution of
biomaterials, there remains a need for further development of stem cell scaffolds that
can accurately recapitulate the structural and physiological aspects of native ECM. The
notable advancements in cellular culture, scaffolds, and integration methods reviewed
here have the potential to lead to groundbreaking clinical products that promote
effective and predictable regeneration of functional tissue.
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2. IN VITRO EVALUATION OF HYBRID SYNTHETIC/ADIPOSE-DERIVED
ECM HYDROGELS AS A CULTURE PLATFORM FOR HUMAN ADIPOSE-DERIVED
STEM CELLS
2.1 Project Purpose

There is a distinct need in the field of tissue engineering for a three-dimensional
scaffold that has the ability to maintain the multilineage differentiation capacity of
mesenchymal stem cells. Human adipose tissue offers an abundant source of allogenic
material that contains ECM proteins, peptides, and glycosaminoglycans.

When

decelluarized and combined with a mechanically tunable polymer, these ECM
components offer the potential to recapitulate the stem cell niche in a more cost-effective
manner than commonly used synthetic peptides.

As described herein, human

decelluarized adipose tissue were incorporated, at varying concentrations, with a thiolacrylate fraction that was then polymerized to produce hydrogels via a Michael addition
reaction. These hydrogels were characterized based on their ability to support the
proliferation, maintain the viability and retain the multipotency of human adipose-derived
stem cells (hASCs). It was found that hASCs encapsulated in hydrogels containing high
concentrations of adipose-derived ECM (adECM) displayed increased expression of
potency markers for a longer duration relative to cells encapsulated in Matrigel or
®

adECM-free PEG hydrogels. These results indicate that adECM hydrogels hold promise
as a cost-effective platform for mesenchymal stem cell multipotency maintenance for
tissue engineering applications.
2.2 Introduction

From the time that mesenchymal stem cells were discovered and used clinically,
there has been a need to expand cells in a native 3D conformation while also maintaining
stem cell potency for future use. Corning Matrigel Matrix revolutionized stem cell culture
®

®

when it was first widely distributed. However, nearly 30 years later, clinicians and
scientists still rely on Matrigel to grow and expand stem cells in 3D. While Matrigel has
®

®

paved the way for many discoveries, it is still unclear what signaling molecules are present
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within the hydrogel. In addition, Matrigel cannot be mechanically or functionally tuned,
®

and there is a high batch-to-batch variability.
Hydrogels’ high water content in addition to their highly tunable functional groups,
degradation schemes, and mechanical properties make them widely used as 3D cellular
scaffolds for stem cell potency maintenance and expansion.98,99 Researchers have
exploited this versatility, combined with synthetic peptides to develop biomimetic
hydrogels that provide microenvironments similar to those observed in native cell
niches.100-105 Extensive research has shown that the structure and content of such
hydrogels can play a critical role in determining cell fate. Synthetic peptides have a
substantial advantage as they are reproducible and can be easily modified for
incorporation into hydrogel networks. However, synthetic peptides are very expensive to
synthesize and purify, limiting the scope and scale of potential applications. As such,
there has been a surge in research dedicated to the development of scaffolds, namely
hydrogels, derived from naturally occurring biological materials. There is evidence that
suggests that these natural biomaterial-laden scaffolds provide a marked increase in
biocompatibility and bioactivity.100,106-109 Incorporation of extracellular matrix (ECM)
isolated from decellullarized tissues in hydrogels has been of particular interest. Cell
adhesion, growth, proliferation, differentiation, and cell fate are heavily dependent on the
signaling molecules and immobilized proteins contained within surrounding ECM.110-111
Many researchers have used detergents, enzymes, and mechanical forces to remove
cellular material while retaining proteins and bioactive molecules.109,112 Processed
ECM can then be incorporated into a synthetic scaffold to create a highly tunable
construct with biological components. Such scaffolds have shown success in facilitating
the regeneration of functional tissue.113,114
Adipose tissue from lipoaspirate is clinical waste that can be used as allogenic
material for the development of ECM-laden constructs. Adipose contains various ECM
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components, such as collagen, reticular fibers, elastin fibers, nerve fibers, vascular
stroma,

lymph

nodes,

and

endocrine

and

paracrine

signaling

molecules.113 Subcutaneous adipose tissue provides a readily accessible source of
allogeneic material, as many healthy individuals electively seek out plastic and
reconstructive surgical procedures to remove unwanted subcutaneous adipose tissue via
liposuction or abdominoplasty. The majority of this human tissue is discarded as medical
waste. Our preliminary results have documented the reproducible ability to decellularize
and extract human adipose tissue ECM (adECM). An evaluation of adECM revealed its
key compositional qualities. Analysis of the peptide fragments by mass spectroscopy
identified 77 individual proteins in the adECM. Nearly 50% of these proteins were
associated with either the extracellular space or the plasma membrane and included
multiple collagen family members. Of the remainder, over 37% had cytoplasmic
associations while ~8% were of nuclear origin. Overall, the adECM proteins identified
were consistent with earlier proteomic analyses of adipose derived cells and
tissues.111,115 Therefore, the reliable incorporation of adECM into a synthetic scaffold
has the potential to be a more cost effective alternative to current commercial peptidebased products.
In this study, we present the synthesis of a hybrid ECM-laden hydrogel to be used as
a 3D scaffold to support human adipose-derived stem cell (hASC) growth and maintain
cellular potency. The adECM was incorporated into a synthetic thiol-acrylate polymer
fraction and polymerized via a base-catalyzed Michael Addition reaction. Modulation of
the reaction conditions affects polymer crosslinking. As such, the Michael Addition
provides the ability to tune the mechanical properties of the polymer fraction, the
component chiefly responsible for the mechanical properties and the degradation profile
of the hydrogel. The adECM, obtained by decellularizing lipoaspirate as described by
McIntosh et. al., was utilized for its array of bioactive molecules and availability.21 The
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integration of adECM with a synthetic polymer provides a dynamic environment that
fosters active cellular responses.
Thiol-acrylate hydrogels laden with varying amounts of adECM were synthesized and
compared. The mechanical properties of each hydrogel were characterized via
compression testing to determine Young’s modulus. Swelling experiments were
conducted to determine swell ratio, cross-link mesh size, and mass loss behavior. Human
adipose-derived stem cells (hASCs) were encapsulated within each hydrogel prior to
polymerization. Cell viability,proliferation, and morphology were evaluated via CCK-8
metabolic assay, Click-iT®Plus EdU assay, and F-actin staining. Maintenance of cell
pluripotency was measured via Q-RT-PCR of the human pluripotency genes SOX2 and

NANOG.
2.3 Materials and Methods

2.3.1 Cell Culture
hASCs were isolated from lipoaspirate obtained from LaCell LLC (New Orleans,
LA). Extracts of subcutaneous adipose tissue were acquired from three consenting
donors undergoing elective plastic surgery under a protocol approved by either the
Pennington Biomedical Research Center Review Board (Baton Rouge, LA) or Western
Institutional Review Board (Puyallup, WA). hASCs were isolated as previously
described.116 hASCs were maintained in T125 flasks at 37˚C at 5% CO in a humidified
2

atmosphere. Cells were allowed to grow until 80% confluent. Second passage (P2) cells
were used in the extraction, DNA synthesis, and quantitative reverse-transcript PCR (qrtPCR) studies.
2.3.2 ECM Decellularization
Adipose tissue (~100g) from two consenting donors (LaCell LLC, New Orleans, LA)
was placed in 200 mL of 3.4 M sodium chloride (NaCl) buffer for 1 hour. The tissue was
then homogenized in solution using an an electric homogenizer (Omni Ultra Shear Small
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Volume). Fibrous tissue that could not be mechanically homogenized was continuously
removed and collected, while all other tissue components were disregarded as
waste. 100 mL of 2 M urea buffer was added to the collected fibrous tissue, and the
solution was refrigerated for 48 hours. The urea/fibrous tissue solution was then
centrifuged three times at 23,000 g at 4 ˚C for 20 minutes. After each centrifugation, the
pelleted tissue was collected and the solvent was discarded as waste. The fibrous pellet
was then dialyzed against deionized water for 24 hours before digestion with 0.5% (w/v)
pepsin in 0.5 M acetic acid. After completion of the digestion reaction, the pepsin was
deactivated by raising the pH of the solution to 9.0 using 1 M sodium hydroxide
(NaOH). The solution was then incubated overnight at 37 ˚C, followed by lowering the
pH of the solution to 7.4 with 1 M hydrochloric acid (HCl). The neutralized solution was
dialyzed again against deionized water for 24 hours before being flash-frozen and
lyophilized to yield a adipose-derived extracellular matrix (adECM) powder. The adECM
powder was gas sterilized with ethylene oxide prior to use.
2.3.3 Protein Quantification
The Pierce™ BCA Assay (ThermoFisher Scientific, USA) was used to determine the
total protein content in ECM samples. Briefly, diluted aliquots (10 μL) were removed (n=3)
from processed ECM and incubated with assay reagents for 30 min at 37 ℃ in a 96-well
plate in accordance with the Pierce™ protocol. The plate was then cooled to room
temperature and absorbance was measured at 532 nm using a fluorescence plate reader
(Wallac 1420 multilabel HTS counter).
2.3.4 Proteomics Analysis
In order to characterize the adECM, liquid chromatography-mass spectroscopy (LCMS) was performed. Samples were prepared by combining 15 µL digestion buffer (8
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mg/mL ammonium bicarbonate in water), 3 µL reducing reagent (30 mg/mL TCEP), and
12 µL sample solution containing 7 µg lyophilized adECM powder or 12 µg BSA standard
protein (total volume 30 µL). The sample was then reduced using TCEP (30 mg/mL) at
50˚C for 7 min, and cooled to room temperature, before being centrifuged to collect the
sample. 3 ul alkylating reagent (18mg/mL iodoacetamide in digestion buffer) was added
to the sample and it was incubated in the dark at room temperature for 20 min. Finally, 3
µL proteomics grade trypsin, activated with ammonium bicarbonate (0.1 µg/µL), was
added to the sample and it incubated at 37 ˚C for 3 hours and stored at -20 ˚C. LCMS/MS analysis was performed using Thermo Finnigan’s ProteomeX workstation LTQ
linear ion trap MS (Thermo Electron, USA). 12 mL of sample was injected into a peptide
trap cartridge (Agilent, USA). The sample was eluted onto a 10-cm reverse-phase Pico
Frit column packed in house with 5 µm, 300 Å pore size C18, and then separated on an
RP column by gradient elution. The mobile phases were H O (A) and ACN (B), both of
2

which contained 0.1% (v/v) formic acid. The flow rate was maintained at 200 nL/min. The
gradient was started at 2% B, reached 60% B in 50 min, 80% B in the next 5 min, and
then 100% A in the final 15 min. Data-dependent acquisition mode (m/z 300-1800) was
enabled, and each survey MS scan was followed by five MS/MS scans with the 30 s
dynamic exclusion option enabled. The spray voltage was 1.9 kV and the temperature of
the ion transfer tube was set at 195 °C. The normalized collision energy was set at
35%. Samples were acquired in triplicates.
2.3.5 Fabrication of adECM Hydrogels
Hydrogel reagents were reacted together employing a thiol-ene base-catalyzed
Michael addition reaction with a 1:1 functional ratio of acrylate to thiol. adECM proteins in
phosphate buffered saline (PBS) were preincubated for 30 minutes with PEG-acrylate
monomers at various concentrations (w/v%) (0%, 0.01%, 0.1%, and 1%).
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During

preincubation, a solution of PBS, ethoxilated-trimethylolpropan tri(3-mercaptopropionate)
(ETTMP 1300, and 1 M NaOH were reacted together in a separate tube. After incubation,
the PEG-acrylate and adECM solution was mixed with the ETTMP 1300 and NaOH
solution. Gelation occurred in less than one minute, and could be controlled by altering
the temperature and the amount of NaOH.
2.3.6 Analysis of adECM Distribution
Hydrogels of various concentrations (0%, 0.01%, 0.1%, 1%) were embedded in
O.C.T for cryosectioning, and stained with Masson’s Trichrome staining kit using the
manufacturer’s protocol. Briefly, the cryosection was stained in working Weigert’s iron
hematoxylin solution for 30 s and washed in deionized (DI) water for 5 min. It was then
placed in biebrich scarlet–acid fuchsin for 5 min. After being rinsed in DI water, the slides
were placed in a phosphomolybdic acid/ phosphotungstic acid solution for 10 min and
then in an aniline blue solution for 7 min. After rinsing briefly DI water, the sections were
placed in a 1% acetic acid solution for 30 s. Slides were then dehydrated and mounted.
Images were taken using a BX51 Olympus microscope.

Collagen distribution was

measured and analyzed via color counting software (Photoshop CS5, Adobe,
USA).117 Each sample was randomly measured in five different positions and four total
samples were included for analysis (n=20).
2.3.7 Mechanical Testing
Hydrogels with protein additives (0%, 0.01%, 0.1%, and 1%) were formed using a 5
mm (height) × 10 mm (diameter) cylindrical mold and allowed to swell overnight before
being tested to determine elastic modulus and maximal compressive strength.118 The
results reported (n=5) were taken with 80% strain at a compression rate of 1 mm/min from
an Instron Mechanical Test System 5696 using an Instron 2 kN static load cell (Instron
Corporation, Canton, MA).
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2.3.8 Swelling and Mass Loss Experiments
Four sets of hydrogels with varying adECM content (0%, 0.01%, 0.1%, 1%) (w/v)
were polymerized via base-catalyzed Michael addition as described above. Upon
formation, hydrogels (135 µL) were incubated at 37 ˚C in 1 mM PBS, pH 7.4. At 0 h, 12
h, 24 h, 48 h, 72 h, 120 h, and 168 h, hydrogel samples were collected, pat dry, and their
mass after swelling (𝑀" ) was recorded. The hydrogel samples were then lyophilized
overnight, and their dry mass was recorded (𝑀# ). Hydrogel swelling ratio (𝑄% ) was then
calculated using Eq. 2.1 below:
𝑄% =

%'

(Eq. 2.1)

%(

Q was then used to calculate the volume swelling ratio (Q ) using Eq. 2.2 below:
M

V

𝑄) = 1 +

,,'

(𝑄% − 1)

(Eq. 2.2)

Where (𝜌2 ) is the density of PEG-acrylate (1.12 g/cm3 ) and is the density of the solvent
(𝜌" ) (1.0 g/cm3 for PBS).
Mass Loss percentage (𝑀. 𝐿. %) was determined using the Eq. 2.3 below:
𝑀. 𝐿. % =

%' 6%(

(Eq. 2.3)

%(

2.3.9 Viability Of hASCs After Acute Exposure To Hydrogel Extracts
The cytotoxic effects of scaffold degradation products were evaluated using Cell
Counting Kit (CCK-8) (Dojindo Molecular Technologies), a commonly used assay to
TM

measure cell viability and proliferation. Following scaffold incubation periods of 7 and 14
days, extracts were filtered. hASCs were seeded at a density of 91 cells/mm for 24 hours
2

in stromal media (DMEM-F12, 10% FBS, 1% Penicillin-Streptomycin-Amphotericin B
solution). The media was replaced with hydrogel extract. hASCs cultured in stromal
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media served as a positive control. After 24 hour incubation at 37 ºC and 5% CO , 100
2

µL of 10% CCK-8 solution were added to each well and samples were incubated at 37 ºC
for 12 hours. The absorbance was measured at 460 nm using a plate reader (Wallac
1420 multilabel HTS counter) and the cell viability was normalized based on the standard
curve.
2.3.10 Encapsulation and Culture of hASCs with Synthetic adECM Hydrogel
hASCs were encapsulated in the scaffolds at 1 x10 cells / mL. Hydrogels were
5

formed in a 96-well plate at a volume of 45 μL and were polymerized at 37 °C to ensure
cell suspension and survivability. Encapsulated cells were cultured in growth media
(Dulbecco's modified Eagle's medium [DMEM/F12], 10% fetal bovine serum [FBS], and
1% Penicillin-Streptomycin-Amphotericin B solution) for up to 14 days with media
maintenance performed three times a week.
2.3.11 EdU Staining
Encapsulated hASCs were characterized based nuclear morphology, and DNA
synthesis rate. In accordance with iClick EdU Andy Fluor 555 Imaging Kit (Genecopoeia)
instructions, the nuceloside analog, EdU (5-ethynyl- 2´-deoxyuridine), was introduced to
culture media four days prior to cell fixation. At 7 and 14 days, scaffolds were fixed in 4%
paraformaldehyde, rinsed three times with PBS, and permeabilized using .5% Triton X100 in PBS. Scaffolds were stained following iClick EdU Andy Fluor 555 Imaging Kit
protocol instructions. To assess nuclear morphology, scaffolds were stained in a 5 μM
DRAQ5 solution (Life Technologies).

Scans for DRAQ5 fluorescence (Ex

max

647,

Em 681), and Andy Fluor 555 fluorescence (Ex 555, Em 565) were performed with a
max

max

max

white light laser at 641 nm and 519 nm, respectively, in the sequential scanning mode at
1024 x 1024 pixel resolution using a 20x objective (HC PL APO CS2 20x/ .70 1mm; Leica,
Bensheim, Germany). Images were brightened uniformly using Adobe Photoshop CC
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2017. Previously described methods were employed to quantify hASC proliferation rate
(n=5).23 Briefly, the Photoshop thresholding tool was used to obtain a cut-off intensity in
images taken at 641 nm (DRAQ5) and 519 nm (Andy Fluor 555). Pixels above the cutoff intensity in groupings with areas greater than 7 μm were considered stained. The
number of Edu-stained cells was divided by the number of DRAQ5-stained cells to obtain
DNA synthesis rate.
2.3.12 F-Actin Staining
To assess cytoskeletal shape, scaffolds were stained in a 200 nM F-actin 488
solution (Life Technologies). Scaffolds were rinsed before being mounted on PBS on a
glass slide and imaged using a Leica TCS SP8 confocal laser scanning
microscope. Scans for Alexa 488 fluorescence (Ex

max

495, Em 518), were performed
max

using a a white laser at 460 nm at 1024 x 1024 pixel resolution using a 20x objective (HC
PL APO CS2 20x/ .70 1mm; Leica, Bensheim, Germany).
2.3.13 Quantitative Real-time Polymerase Chain Reaction
RNA was isolated from encapsulated scaffolds as previously described.119

In

addition, RNA was purified using the PureLink RNA Minin Kit in accordance with
®

manufacturer’s instructions. Total RNA to cDNA EcoDry Premix (ClonTech) was used
for cDNA synthesis. qRT-PCR was performed using 2× iTaq SYBR green supermix with
ROX (Biorad) and primers for SRY-related HMG-box (SOX2) and human NANOG
(hNANOG) to quantify gene expression associated with maintenance of multipotency in
hASCs encapsulated into hydrogels and cultured for 7 and 14 days. Reactions were
performed with a MJ Mini Thermal Cycler (BioRad). The sequences of PCR primers
(forward

and

backward,

TACAGCATGTCCTACTCGCAG-3,

5’−3’)

were

and,

5'

as

follows:

SOX2,

5'-

GAGGAAGAGGTAACCACAGGG-3’;

hNANOG, 5’- ATGCCTCACACGGAGACTGT-3’ and 5’- GGGCTGTCCTGAATAAGCA3’. Samples were normalized (ΔCt) against the housekeeping gene 18S rRNA (forward
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and

backward,

5’-3’):

CCTCCAATGGATCCTCGTTA-3’.

5’-AAACGGCTACCACATCCAAG-3’

and

5’-

The - ΔΔCt value of SOX2 and hNANOG in

encapsulated polymers was calculated using the ΔΔCt method.
2.3.14 Statistical Analysis
All results were expressed as mean ± standard deviation. Data were analyzed with
one-way analysis of variance, followed by Tukey's minimum significant difference post

hoc test for pairwise comparisons of main effects. For all comparisons, a p-value < 0.05
was considered significant.
2.4 Results

2.4.1 Hydrogel Synthesis
In this study, the effects of adECM hydrogels on encapsulated hASCs were
evaluated. A schematic for adECM incorporation and hydrogel polymerization is
presented in Scheme 2.1.

+

+
adECM

ETTMP*

4-arm PEG Acrylate
1. hASCs
2. Sodium
Hydroxide

Hydrogel adECM concentrations (w/v):
0%
0.01%
0.1%
1%
* = Ethoxilated-Trimethylolpropan
Tri(3-Mercaptopropionate)

adECM Hydrogel

Scheme 2.1 - hASC encapsulation and adECM hydrogel fabrication.
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2.4.2 Liquid Chromatography-Mass Spectroscopy
LC-MS was used to characterize proteins found in adECM. Three distinct proteins
were identified (Table 2.1). Collagen, type I, alpha 2 was found in all three of the
samples. Collagen, type I, alpha 1 was found in samples 1 and 3. Finally, collagen type
III alpha 1 was identified only in sample 3 (Table 2.2). The results are consistent with
other studies performed by Edwin C.M. et al.118
2.4.3 adECM Distribution
Masson’s Trichrome staining was performed to investigate the distribution of adECM
collagen in all adECM hydrogel compositions. Significantly more collagen, stained blue,
was found in the 1% adECM group , compared to the 0.1% adECM hydrogel, the 0.01%
adECM hydrogel and the 0% adECM group (Figure 2.1) In all samples, collagen, when
present, appeared to be punctate and not uniformly distributed throughout the scaffold
(Figure 2.2).

Table 2.1 - Identification of proteins in adECM
Protein Name
Collagen alpha-2 (I) chain [Human]
Collagen alpha-2 (I) chain [Human]
Collagen alpha-3 (III) chain [Human]

UniProt acession no.
A0A087WTA8
P02452
P02461

Table 2.2 - Distribution of proteins among tested adECM samples
Sample
1

Protein
Collagen alpha-2(I) chain [Human]
Collagen alpha-1(I) chain [Human]

2

Collagen alpha-2(I) chain [Human]

3

Collagen alpha-2(I) chain [Human]
Collagen alpha-1(I) chain [Human]
Collagen alpha-1(III) chain [Human]
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M.W. (kDa)
129.1
138.9
138.5

Figure 2.1 - Collagen content of adECM hydrogels.
significant.

All samples are statistically

Figure 2.2 - Masson’s Trichrome staining of adECM hydrogels. A, D) 1% adECM, B), E)
0.1% adECM, C), F) 0.01% adECM, G), F), H) 0% adECM. Collagen is stained blue.
For A, B, C&G, the scale bar is 1 mm and for D,E, F&H, the scale bar is 200 um.
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2.4.4 Mechanical Characterization
Figure 2.3 shows the mechanical strength data for hydrogel scaffolds containing
different concentrations of adECM. Increasing adECM concentration, lead to a decrease
in Young’s modulus. Hydrogels containing 0.01%, 0.1%, and 1% displayed a decreasing
trend in Young’s Modulus.

** statistical significance, p < 0.05, * statistically significant than ** values, p < 0.05.

Figure 2.3 - Young’s modulus of PEG hydrogels with varying concentrations of adECM
additives.
2.4.5 Swelling and Mass Loss
Scaffolds containing adECM were assessed for changes in swelling, mesh size, and
mass-loss during incubation.

Hydrogel swell ratio over the course of 168 hours is

displayed in Figure 2.4. Scaffolds containing 1% adECM showed increased swelling size
between 120 and 168 hours compared to all other scaffold samples. There were no
significant differences in swell ratio noted among scaffolds containing 0%, 0.01%, and
0.1% adECM across all recorded time points. Scaffold mass loss was evaluated up to
168 hours (Figure 2.5). From 12 to 120 hours, hydrogels containing 1% adECM exhibited
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mass loss to the greatest extent compared to all other scaffold samples. At 168 hours,
hydrogels containing 1% adECM showed increased mass loss compared to scaffold
groups containing 0% and 0.1% adECM. At 24 and 48 hours, hydrogels containing 0.1%
adECM displayed greater mass loss compared to samples containing 0.01% adECM,
however, at 168 hours, scaffolds containing 0.01% adECM showed increased mass loss
compared to 0.1% adECM samples.

Figure 2.4 - Swelling ratio for PEG hydrogels with varying concentrations of adECM
additives expressed over an incubation period of 168 hours. Error bars shown. 1%
adECM hydrogel was found to have a significantly higher swell ratio at 168 hours than
the rest of the samples.

Figure 2.5 - Mass loss of PEG hydrogels containing varying concentrations of adECM
additives expressed as percent lost over an incubation time of 168 hours. 1% adEM
hydrogels displayed significantly increased mass loss compared to all other samples at
12, 24, 48, 72, and 120 hours. At 168 hours, 1% adECM hydrogels displayed significantly
increased mass loss compared to 0.1% and 0% adECM hydrogel samples.
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2.4.6 hASC Viability After Exposure to Scaffold Extracts
Viability of hASCs following exposure to hydrogel extracts is shown in Figure 2.6.
Compared to cells cultured in stromal media, hASCs exposed to extracts of scaffolds
containing 0%, 0.01%, 0.1%, and 1% adECM displayed no significant difference in
viability at both 7-day and 14-day time points.

Figure 2.6 - Cell viability for PEG extracts with varying concentrations of adECM additives.
Extracts were taken after either 7 or 14 days of incubation. Values were normalized to a
live control of hASCs cultured in stromal media.
2.4.7 hASC Morphology and DNA Synthesis
Corresponding confocal imaging of hASCs (Figure 2.7 and Figure 2.8) showed cells
encapsulated in Matrigel to have a greater number of protrusions than those cultured in
®

PEG-based scaffolds at 7 days. At 14 days, hASCs cultured in Matrigel displayed more
®

aligned, stretched and organized development of F-actin in comparison to PEG-based
scaffolds. Qualitatively, no significant cellular morphological changes were appreciated
within adECM hydrogel groups between 7 and 14 days. Image analysis using DRAQ5
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and EdU staining indicated significant cellular proliferation rates for only Matrigel

®

between 0 and 7 days (214% ± 34%) and 7 and 14 days (288% ± 57%).

A

B

C

D

E

A’

B’

C’

D’

E’

A’’

B’’

C’’

D’’

E’’

A’’’

B’’’

C’’’

D’’’

E’’’

Figure 2.7 - Images acquired at 7 days using Leica SP8. Scale bars = 50 µm. hASCs
encapsulated in Matrigel samples stained with DRAQ5 (Blue) (A) and F-Actin (Green)
(A’’) exhibited a greater number of protrusions compared to cells in 0% adECM (B,B’’),
0.01% adECM (C,C’’), 0.1% adECM (D,D”), 1% adECM (E,E”) hydrogel samples. hASCs
in Matrigel stained with Edu (Red) (A’) displayed a proliferation rate of (214% ± 34%)
between 0 and 7 days. PEG-hydrogel samples did not display significant proliferation
rates (B’-E’).
®

®
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F

G

H

I

J

F’

G’

H’

I’

J’

F’’

G’’

H’’

I’’

J’’

F’’’

G’’’

H’’’

I’’’

J’’’

Figure 2.8 - Images acquired at 14 days using Leica SP8. Scale bars = 50 µm. hASCs
encapsulated in Matrigel samples stained with DRAQ5 (Blue) (F) and F-Actin (Green)
(F’’) demonstrated more aligned, stretched and organized development of F-actin
compared to cells in 0% adECM (G,G”), 0.01% adECM (H,H”), 0.1% adECM (I,I”), 1%
adECM (J,J”) hydrogel samples. hASCs in Matrigel stained with Edu (Red) (F’) displayed
a proliferation rate of (288% ± 57%) between 0 and 14 days. PEG-hydrogel samples did
not display significant proliferation rates (G’-J’).
®

®

2.4.8 Quantitative Reverse-transcript PCR of Human Pluripotency Markers
Analysis of gene expression markers of pluripotency indicated that 0.1% and 1%
adECM groups had significantly higher levels of both NANOG (Figure 2.9) and SOX2
26

(Figure 2.10) gene expression compared to Matrigel and 0% adECM samples at both 7
®

and 14 days. At both time points, there was no significant difference in NANOG or SOX2
expression between the 0.1% adECM and 1% adECM groups.

** statistical significance, p < 0.05.

Figure 2.9 - Relative expression levels of NANOG in Matrigel and PEG hydrogels with
adECM additives after 7 and 14 days in culture.
®

** statistical significance, p < 0.05.

Figure 2.10 - Relative expression levels of SOX2 in Matrigel and PEG hydrogels with
adECM additives after 7 and 14 days in culture.
®
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2.5 Discussion

hASCs were used to evaluate the impact of different adECM compositions in PEGacrylate hydrogels on cell behavior. Corning®® Matrigel® was used as a positive control
because of its wide use in 3D cell culture.
To address the need for a mechanically tunable, cost-effective 3D scaffold that
supports stem cell viability and maintains cellular potency, adipose was decellularized
and incorporated with a thiol-acrylate polymer fraction that was then polymerized to
produce a hydrogel. Scaffolds of various adECM concentrations were evaluated. ECM
additives beyond 1% of total volume did not disperse homogeneously, leading to an
unstable hydrogel. Therefore, experiments were designed to test the physical and
physicochemical properties of PEG hydrogels with adECM concentrations (w/v) of 0%,
0.01%, 0.10%, or 1%.
Hydrogel swelling is dependent upon the polymer network structure, cross-linking
density, and hydrophilicity. The equilibrium degree of swelling was experimentally
determined for each hydrogel. Initial mechanical studies examined the swelling, mass
loss, and porosity of the hydrogel scaffolds. Results indicated that the elastic modulus of
PEG hydrogels with adECM concentrations of 0.01% and 0.10% was not significantly
different than that of hydrogels containing 0% adECM. Hydrogels containing 1% adECM
showed significantly a lower Young’s modulus than all other experimental PEG hydrogels.
Similarly, 1% adECM hydrogels displayed significantly more rapid rates of mass loss and
greater degrees of swelling. We hypothesize that this phenomenon could be caused by
a greater degree of steric hindrance during polymerization, resulting in less efficient
crosslinking in hydrogels with higher adECM concentrations. However, 1% adECM
hydrogels showed approximately a one hundred-fold increase in elastic modulus
compared to Matrigel® (450 Pa).120 In addition, the degrees of stiffness of the PEG-
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based hydrogels evaluated in this study were, overall, greater than those of many other
reported PEG-based hydrogels.121-126
After mechanical characterization, subsequent studies focused on assessing hASC
viability, proliferation, morphology and differentiation capacity upon encapsulation in
hydrogels containing varying amounts of adECM. When exposed to hydrogel extracts,
hASCs exhibited no loss of viability in comparison to growth media controls. These
results are in agreement with previous findings from PEG based hydrogel extracts studies
where mouse fibroblasts (Balb/3T3)) were treated with extracts from PEG-vinyl Sulfone
hydrogels.126 Characterization utilizing EdU staining assay indicated decreased DNA
synthesis in adECM hydrogels relative to Matrigel® controls at both 7 and 14 days. In
addition, qualitative examination of F-actin and DRAQ5 staining results suggested little
difference in cellular morphology among PEG hydrogels, but substantial difference at 14
days between Matrigel® and PEG scaffolds. Previous studies have shown that cells
proliferate more rapidly in hydrogels containing immobilized matrix proteins, such as
RGD. The effects of the adECM additives may have been greater if the matrix proteins
were bound. In addition, the study found that greater hydrogel stiffness amplified the
effects of the membrane proteins.127 Therefore, the lower adECM concentrations may
result in higher cell proliferation due to the effects of matrix stiffness on ECM additives.
Finally, RT-qPCR results indicated that cells encapsulated in all PEG hydrogel
samples initially exhibited significantly higher NANOG and SOX2 expression compared
to Matrigel® samples, and that hydrogels containing higher concentrations of adECM
maintained increased expression of both genes at 14 days. Yu et al. demonstrated that
hASCs expanded on decellularized adipose tissue microcarriers maintained their
trilineage differentiataion capacity to a greater extent than those cultured on
commercially-sourced Cultispher-S microcarriers, suggesting that adipose-derived ECM
scaffolds may have the ability to conserve mulipotency in hASCs to a larger degree than
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commonly used commercial scaffold platforms.128 Further studies must be performed
in order to further confirm the ability of adECM hydrogels to maintain multipotency in
hASCs.
Our work highlights that the addition of adECM to otherwise biologically inactive
scaffolds can significantly alter the potency potential of encapsulated hASCS. adECM
hydrogels have the capability to be further developed for use in multipotency maintenance
in stem cells.

Tuning the mechanical characteristics, adECM content, and seeding

density of the platform has the potential to lead to the enhancement of cellular expansion
and multilineage differentiation capacity.
2.6 Conclusion

Over the course of this study, we decellularized and processed adipose-derived ECM
in a form usable for a number of tissue engineering applications. adECM was
incorporated in varying concentrations into a PEG-acrylate hydrogel. Analysis suggested
that, like Matrigel , adECM-composite hydrogels provide a microenvironment that is able
®

to sustain cell viability. However, the physicochemical and mechanical properties of PEGacrylate hydrogels can be easily manipulated and finely tuned to satisfy the needs of
project-specific applications. Overall, this technology can be versatile for the growth and
expansion of mesenchymal stem cells. In addition, adECM can be processed from
abundant lipoaspirates, which are often discarded as medical waste, providing a low cost
source of bioactive material for use in scaffold fabrication. Further studies need to be
conducted to compare cell behavior in the presence of synthetic peptides. We would
hypothesize that signaling molecules and membrane proteins present in ECM would
provide a more finely-tuned cell niche than synthetic peptides alone.
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3. PRELIMINARY EVALUATION OF HYBRID SYNTHETIC/THIOLATED ADIPOSEDERIVED ECM HYDROGELS
3.1 Project Purpose

Inspired by the findings that adipose-derived ECM can be converted into a
cytocompatible hydrogel after combination with a synthetic thiol-acrylate fraction, efforts
were conducted in order to improve the performance of the hybrid synthetic/adiposederived ECM hydrogel platform. In this study, adipose-derived ECM was thiolated prior
to hydrogel polymerization via a ring opening polymerization in order to promote more
uniform dispersion and greater concentration of adECM proteins. adECM was
incorporated, at varying concentrations, with a synthetic thiol-acrylate fraction that was
then polymerized to produce hydrogels via a Michael addition reaction, as described in
Chapter 2 of this thesis. Hydrogels were characterized based on their stiffness and ability
to maintain the viability human adipose-derived stem cells (hASCs). It was found that
hASCs seeded on hydrogels containing higher concentrations of thiolated adECM
(tadECM) demonstrated decreased viability compared to tadECM-free hydrogels. These
results indicate that tadECM hydrogels may need to be further improved as stem cell
scaffolds, possibly by increasing tadECM functionality.
3.2 Introduction

The ability to obtain uniformity in scaffold structure has been demonstrated to greatly
improve stem cell spatial distribution, growth and proliferation. Moreover, it can lead to a
more committed differentiation pathway.129 Decellularized adipose-derived extracellular
matrix has been found to induce adipogenesis in hASCs both in vitro and in vivo.113,130
These scaffolds have been shown to have high concentrations of ECM proteins, however,
they

are

relatively

mechanically

unstable

compared

to

synthetic

polymer

platforms.131,132
In this preliminary study, we present a strategy for increasing the ECM content in
synthetic ECM/PEG hydrogel by using adipose-derived ECM that has been thiolated via
a ring opening polymerization. Thiolation efficiency was quantified prior to the synthesis
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of three hydrogels containing various thiolated adECM (tadECM) compositions. The
mechanical

properties

of

hydrogels

with

different

ECM

concentrations

were

characterized. In addition, viability of hASCs seeded on the hydrogels was assessed.
3.3 Materials and Methods

3.3.1 ECM Decellularization
Adipose tissue was decellularized as previously described in Chapter 2 of this thesis,
briefly, (~100g) was placed in 200 mL of 3.4 M sodium chloride (NaCl) buffer for 1 hour.
The tissue was then homogenized using an electric homogenizer (Omni Ultra Shear
Small Volume).

Fibrous tissue that could not be mechanically homogenized

removed. 100 mL of 2 M urea buffer was then added to the collected fibrous tissue, and
the solution was refrigerated for 48 hours. The fibrous tissue was centrifuged three times
at 23,000 g at 4 ˚C for 20 minutes. The fibrous pellet was then dialyzed against deionized
water for 24 hours before digestion with 0.5% (w/v) pepsin in 0.5 M acetic acid. After
completion of the digestion reaction, the pepsin was deactivated by raising the pH of the
solution to 9.0 using 1 M sodium hydroxide (NaOH). The solution was then incubated
overnight at 37 ˚C, followed by lowering the pH of the solution to 7.4 with 1 M hydrochloric
acid (HCl). The neutralized solution was dialyzed again against deionized water for 24
hours before being flash-frozen and lyophilized to yield a decellularized, adipose-derived
extracellular matrix (adECM) powder.
3.3.2 Protein Quantification
The Pierce™ BCA Assay (ThermoFisher Scientific, USA) was used, as described in
Chapter 2 of this thesis, to determine the total protein content in ECM samples. Diluted
aliquots of processed ECM (10 μL) were removed (n=3) and incubated with assay
reagents for 30 min at 37 ℃ in a 96-well plate in accordance with the Pierce™ protocol.
The plate was then cooled to room temperature and absorbance was measured at 532
nm using a fluorescence plate reader (Wallac 1420 multilabel HTS counter).
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3.3.3 ECM Thiolation
adECM was thiolated as previously described.133 Briefly, adECM (80 mg) was
immersed in 20 mL EtOH: PBS 1:1 (v/v) solution containing 0.033 M γ-thiobutyrolactone
at room temperature for 24 h. Then, the pH of the solution was lowered to 5 for 10 min
using acetic acid (Sigma). The solution was dialyzed against deionized water overnight,
then lyophilized. Thiolation efficiency was calculated using the DTNB colorimetric assay
(Sigma). The thiolated adipose-derived ECM (tadECM) powder was sterilized with
ethylene oxide prior to use in vitro.
3.3.4 Fabrication of tadECM Hydrogels
Hydrogel reagents were reacted together employing a thiol-ene base-catalyzed
Michael addition reaction with a 1:1 functional group ratio of acrylate to thiol. tadECM
proteins in phosphate buffered saline (PBS) were preincubated for 30 minutes with PEGacrylate

monomers.

During

preincubation,

a

solution

of

PBS,

ethoxilated-

trimethylolpropan tri(3-mercaptopropionate) (ETTMP 1300, and 1 M NaOH were reacted
together in a separate tube. After incubation, the PEG-acrylate and adECM solution was
mixed with the ETTMP 1300 and NaOH solution. Hydrogels were synthesized at 1: 1: 0,
1: 0.25: 0.75, 1: 0.5: 0.5 (PEG-acrylate: ETTMP: tadECM) by molar functionality. Gelation
occurred in less than one minute, and could be controlled by adjusting the temperature
and amount of NaOH .
3.3.5 Mechanical Testing
Hydrogels with protein additives (1: 1: 0, 1: 0.25: 0.75, 1: 0.5: 0.5) were formed using
a 5 mm (height) × 10 mm (diameter) cylindrical mold and allowed to swell overnight before
being tested to determine elastic modulus and maximal compressive strength.118 The
results reported (n=5) were taken with 80% strain at a compression rate of 1 mm/min from
an Instron Mechanical Test System 5696 using an Instron 2 kN static load cell (Instron
Corporation, Canton, MA).
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3.3.6 Seeding and Culture of hASCs with Synthetic adECM Hydrogel
Hydrogels were formed in a 2 mm (height) x 5 mm (diameter) cylindrical mold before
being transferred to a 48-well plate and allowed to swell in PBS overnight. Cells were
isolated and cultured as described in Chapter 2 of this thesis. Second passage (P2)
hASCs were seeded on the hydrogels at a density of 25,000 cells / scaffold. Cells were
cultured in growth media (Dulbecco's modified Eagle's medium [DMEM/F12], 10% fetal
bovine serum [FBS], and 1% Penicillin-Streptomycin-Amphotericin B solution) for 7 days
with media maintenance performed three times a week.
3.3.7 Live/Dead® Staining
At 7 days, cell viability was assessed using the Live/Dead® viability/cytotoxicity kit
(Molecular Probes, Eugene, OR). Each specimen was incubated in a 0.2% ethidium
homodimer, 0.05% calcein am (v/v) solution in PBS (-Ca, -Mg), protected from light, for
45 min. Cells were visualized via fluorescence microscopy (Zeiss Stereo Lumar) in
combination with a digital camera (Hamamatsu Orca ER cooled CCD).
3.3.8 Statistical Analysis
All results were expressed as mean ± standard deviation. Data were analyzed with
one-way analysis of variance, followed by Tukey's minimum significant difference post

hoc test for pairwise comparisons of main effects. For all comparisons, a p-value < 0.05
was considered significant.
3.4 Results

3.4.1 adECM Thiolation and Hydrogel Synthesis
In this study, the effects of tadECM hydrogels on hASCs were evaluated. A
schematic for adECM thioaltion and hydrogel polymerization is presented in Scheme 3.1
and Scheme 3.2, respectively. tadECM thiolation effiency, as evaluated using the DTNB
assay, was reported to be 248.7 µmol / g ± 1.6 µmol / g. For comparison, unmodified
adECM was found to have a thiol concentration of 104.2 µmol / g ± .6 µmol / g.
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Scheme 3.1 - adECM thiolation via ring opening polymerization.
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Scheme 3.2 - Synthesis of tadECM hydrogel using tadECM, 4-arm PEG acrylate, and
ETTMP. Reaction was catalyzed using sodium hydroxide.
3.4.2 Mechanical Characterization
Figure 3.1 shows the mechanical strength for hydrogel scaffolds containing different
concentrations of tadECM. There was no significant difference in Young’s modulus
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between hydrogel the 1: 1: 0 and 1: 0.75: 0.25 formulation groups. A significant difference
in Young’s modulus was observed between the 1: 0.5: 0.5 hydrogel formulation group
and the 1: 1: 0 and 1: 0.25: 0.75 groups.

** statistical significance, p < 0.05.

Figure 3.1 - Young’s modulus of PEG hydrogels with varying concentrations of tadECM
additives.
3.4.3 hASC Viability
Figure 3.2 shows hASCs stained with the Live/Dead® staining kit at 7 days.
Qualitatively, hASCs seeded on 1: 1: 0 hydrogels exhibited greater viability at 7 days than
cells seeded on either 1: 0.25: 0.75 or 1: 0.5: 0.5 scaffolds. In addition, cells appeared to
remain adhered to the surface of the 1: 1: 0 formulation hydrogel compared to either the
1: 0.25: 0.75 or 1: 0.5: 0.5 groups.
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1 : 0: 1

1: 0.25: 0.75

1: 0.5: 0.5

Figure 3.2 - Scale bar = 150 µm. tadECM hydrogels stained with Live/Dead® kit.
3.5 Discussion

adECM was thiolated prior to incorporation with a PEG-acrylate/ETTMP polymer
fraction to produce a hydrogel. tadECM thiolation was found to be 248.7 µmol / g ± 1.6
µmol / g. This degree of substitution is comparable to the results of Xu et. al, who
demonstrated an experimental collagen thiolation efficiency of 297 µmol / g ± 1.6 µmol /
g.134
Mechanical characterization of 1: 1: 0, 1: 0.5: 0.5, and 1: 0.25: 0.75 tadECM hydrogel
groups demonstrated that a decrease in Young’s modulus correlated with an increase in
tadECM content and a decrease in ETTMP concentration. This may due to a lower
conversion rate for hydrogel groups with high concentrations of tadECM. Similarly, Artzi
et. al found that incomplete monomer conversion was responsible for decreased
mechanical strength.135
Finally, Live/Dead® staining of tadECM hydrogels revealed that decreased cell
viability correlated with increased tadCM content and decreased ETTMP concentration.
These results could be caused by unreacted acrylate groups, which have been found to
be relatively cytotoxic in vitro.136
Overall, the results of this preliminary study indicated that more complete thiolacrylate conversion in hydrogel synthesis should be obtained in order to improve both
the mechanical and cytocompatibility properties of the tadECM scaffold. This may be
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addressed thiolating adECM to a greater degree by, first, increasing the amount of
lysines present in the protein structure. Xu et. al was able to accomplish this goal by
subjecting collagen to a carboxylation reaction, followed by an amidation reaction with
2-mercaptoethylamine hydrochloride (MEA) and a EDC-NHS (EDC: 1-(3dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; NHS: N-hydroxysuccinimide)
condensation reaction.134
3.6 Conclusion

In this study, we successfully thiolated adECM and synthesized a hybrid
synthetic/tadECM hydrogel. However, mechanical and cytocompatibility studies revealed
that reduced Young’s modulus and cell viability correlated with increased tadECM
content. As these results may be caused by incomplete thiol-acryalte conversion, future
work will focus on improving tadECM functionality. We would hypothesize that increasing
the number of tadECM thiol functional groups would lead to improved outcomes.
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4. SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
4.1 Summary

ECM-based hybrid hydrogels are currently being used in the field of tissue
engineering to in an effort to promote stem cell proliferation and differentiation. In these
studies, hybrid synthetic/adipose-derived ECM scaffolds were characterized based on
their mechanical properties and ability to support hASC proliferation, viability and
multipotency preservation.
Inspired by the findings that adipose-derived ECM can be converted into a
cytocompatible hydrogel after combination with a synthetic fraction, efforts were
conducted in order to improve the performance of the hybrid synthetic/adipose-derived
ECM hydrogel platform. ECM was thiolated prior to hydrogel synthesis in order to
promote more uniform dispersion. Thiolated adipose-derived ECM hydrogels were
characterized based on their elasticity and ability to maintain hASC viability.
4.2 Conclusions

hASCs encapsulated in hybrid synthetic/adipose-derived ECM hydrogels
containing high concentrations of ECM demonstrated greater expression of human
potency markers compared to cells encapsulated in ECM-free synthetic hydrogels or in
Matrigel®. These results indicate that adECM hydrogels hold promise as a costeffective platform for hASC multipotency maintenance in tissue engineering
applications.
It was found that hASCs seeded on synthetic hybrid hydrogels containing higher
concentrations of thiolated adECM (tadECM) demonstrated decreased viability compared
to tadECM-free hydrogels. As these results may be caused by incomplete thiol-acrylate
conversion, increasing the thiol concentration of the tadECM prior to hydrogel synthesis
may lead to improved outcomes.
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4.3 Recommendations

1. Further validation of the multipotency maintenance capability adECM hydrogels is
needed to evaluate their potential as stem cells scaffolds.
2. Studies investigating the ability of hybrid adECM hydrogels to affect hASC
trilineage differentiation are needed in order to asses their capacity to facilitate
tissue regeneration. Additives, such as β-TCP, hydroxyapatite, TGF- β3, or BMP6, may assist in promoting a specific stem cell lineage.
3. Enhanced adECM dispersion in the hydrogels may improve stem cell spatial
distribution and proliferation. It may also lead to a more committed differentiation
pathway.

This may be achieved by increasing the thiol concentration of the

adECM.
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